Next Article in Journal
A Single Center Analysis of Thymic Neuroendocrine Tumors
Next Article in Special Issue
ERBB2 Amplification as a Predictive and Prognostic Biomarker in Upper Tract Urothelial Carcinoma
Previous Article in Journal
Roles of Chromatin Remodelling and Molecular Heterogeneity in Therapy Resistance in Glioblastoma
Previous Article in Special Issue
CD8A as a Prognostic and Immunotherapy Predictive Biomarker Can Be Evaluated by MRI Radiomics Features in Bladder Cancer
 
 
Article

Article Versions Notes

Cancers 2022, 14(19), 4943; https://doi.org/10.3390/cancers14194943
Action Date Notes Link
article pdf uploaded. 9 October 2022 11:20 CEST Version of Record https://www.mdpi.com/2072-6694/14/19/4943/pdf-vor
article supplementary file uploaded. 9 October 2022 11:20 CEST - https://www.mdpi.com/2072-6694/14/19/4943#supplementary
article xml file uploaded 11 October 2022 08:54 CEST Original file -
article xml uploaded. 11 October 2022 08:54 CEST Update -
article pdf uploaded. 11 October 2022 08:54 CEST Updated version of record https://www.mdpi.com/2072-6694/14/19/4943/pdf-vor
article html file updated 11 October 2022 08:55 CEST Original file -
article html file updated 11 October 2022 10:26 CEST Update -
article xml file uploaded 13 October 2022 06:12 CEST Update -
article xml uploaded. 13 October 2022 06:12 CEST Update https://www.mdpi.com/2072-6694/14/19/4943/xml
article pdf uploaded. 13 October 2022 06:12 CEST Updated version of record https://www.mdpi.com/2072-6694/14/19/4943/pdf
article html file updated 13 October 2022 06:13 CEST Update -
article html file updated 28 February 2023 17:14 CET Update -
article html file updated 1 March 2023 20:21 CET Update https://www.mdpi.com/2072-6694/14/19/4943/html
Back to TopTop